• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肌层浸润性膀胱癌患者复发的预测。患者特征重要吗?

Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?

作者信息

Ucpinar Burak, Erbin Akif, Ayranci Ali, Caglar Ufuk, Alis Deniz, Basal Seref, Sarilar Omer, Akbulut Mehmet Fatih

机构信息

Department of Urology, Haseki Training and Research Hospital, Istanbul, Turkey.

出版信息

J BUON. 2019 Jul-Aug;24(4):1659-1665.

PMID:31646822
Abstract

PURPOSE

To evaluate patients, diagnosed with non-muscle invasive bladder cancer, according to patient specific parameters including hemoglobin level, estimated glomerular filtration rate (eGFR), body mass index (BMI) and cigarette smoking and to identify if any of these parameters matters in terms of recurrence prediction.

METHODS

231 patients who have undergone transurethral resection of the bladder (TURB) between January 2015 and January 2018 and diagnosed with non-muscle invasive bladder cancer (NMIBC) were included. Patient demographic characteristics including age, sex, BMI and cigarette smoking were assessed. Hemoglobin, creatinine and eGFR values were recorded. Follow-up was performed according to the European Association of Urology (EAU) guidelines' recommendations. Recurrence and progression during follow-up were recorded.

RESULTS

231 patients were included in the study. Median patient BMI, Hb levels, and eGFR values were 26.51 kg/m2 (IQR 5.48), 14,2 g/dL (IQR 2.50), and 83.25 ml/min/1.73m2 (IQR 27.83), respectively. Among all patients, 105 (45%) were ex-smokers and 78 (33%) were current smokers, 41 had anemia (17.7%), 37 (16%) patients were obese; 104 (45%) had mildly impaired renal function and 34 (14.7%) had impaired renal function. During follow-up, 67 (29%) patients had disease recurrence and 21 (9.1%) had disease progression (9.1%). Univariate and multivariate analyses revealed significant relationship between recurrence and obesity, impaired renal function and cigarette smoking.

CONCLUSIONS

Recurrence is a commonly encountered unfortunate consequence of NMIBC, and obesity, renal failure, history of smoking and anemia seem to increase the rate of recurrence among bladder cancer patients.

摘要

目的

根据患者特定参数(包括血红蛋白水平、估计肾小球滤过率(eGFR)、体重指数(BMI)和吸烟情况)对诊断为非肌肉浸润性膀胱癌的患者进行评估,并确定这些参数中的任何一个在复发预测方面是否具有重要意义。

方法

纳入2015年1月至2018年1月间接受经尿道膀胱肿瘤切除术(TURB)并诊断为非肌肉浸润性膀胱癌(NMIBC)的231例患者。评估患者的人口统计学特征,包括年龄、性别、BMI和吸烟情况。记录血红蛋白、肌酐和eGFR值。根据欧洲泌尿外科学会(EAU)指南的建议进行随访。记录随访期间的复发和进展情况。

结果

231例患者纳入研究。患者的BMI中位数、血红蛋白水平和eGFR值分别为26.51kg/m²(四分位间距5.48)、14.2g/dL(四分位间距2.50)和83.25ml/min/1.73m²(四分位间距27.83)。在所有患者中,105例(45%)为既往吸烟者,78例(33%)为当前吸烟者,41例有贫血(17.7%),37例(16%)患者肥胖;104例(45%)肾功能轻度受损,34例(14.7%)肾功能受损。随访期间,67例(29%)患者疾病复发,21例(9.1%)患者疾病进展(9.1%)。单因素和多因素分析显示复发与肥胖、肾功能受损和吸烟之间存在显著关系。

结论

复发是非肌肉浸润性膀胱癌常见的不良后果,肥胖、肾衰竭、吸烟史和贫血似乎会增加膀胱癌患者的复发率。

相似文献

1
Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?非肌层浸润性膀胱癌患者复发的预测。患者特征重要吗?
J BUON. 2019 Jul-Aug;24(4):1659-1665.
2
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.分层对经尿道膀胱肿瘤切除术治疗的原发性高危非肌肉浸润性膀胱癌患者肿瘤学结局预测的影响。
Urol Oncol. 2020 Oct;38(10):795.e9-795.e17. doi: 10.1016/j.urolonc.2020.04.023. Epub 2020 May 14.
3
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
4
Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.吸烟状态和累积吸烟暴露对非肌层浸润性膀胱癌肿瘤复发的影响。
Int Urol Nephrol. 2017 Jan;49(1):69-76. doi: 10.1007/s11255-016-1441-6. Epub 2016 Oct 20.
5
The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).低强度与高强度监测膀胱镜检查对高危非肌肉浸润性膀胱癌(NMIBC)患者的手术护理和癌症结局的影响。
PLoS One. 2020 Mar 23;15(3):e0230417. doi: 10.1371/journal.pone.0230417. eCollection 2020.
6
Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression--introducing a novel prognostic model for bladder cancer recurrence.估算肾小球滤过率受损是非肌层浸润性膀胱癌复发和进展的重要预测指标——引入一种新的膀胱癌复发预后模型。
Urol Oncol. 2014 Nov;32(8):1178-83. doi: 10.1016/j.urolonc.2014.05.009. Epub 2014 Jun 21.
7
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
8
Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.戒烟15年或更长时间可降低非肌层浸润性膀胱癌患者肿瘤复发风险。
Ann Surg Oncol. 2016 May;23(5):1752-9. doi: 10.1245/s10434-015-5016-z. Epub 2015 Dec 15.
9
Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.细胞周期标志物并不能提高欧洲癌症研究与治疗组织(EORTC)和CUETO风险模型在预测非肌层浸润性高级别膀胱癌复发和进展方面的鉴别能力。
Urol Oncol. 2016 Nov;34(11):485.e7-485.e14. doi: 10.1016/j.urolonc.2016.05.014. Epub 2016 Sep 13.
10
Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.首次经尿道膀胱肿瘤切除时估计肾小球滤过率降低(eGFR<60 mL/min/1.73 m²)是随后复发和进展的重要预测指标。
BJU Int. 2017 Sep;120(3):387-393. doi: 10.1111/bju.13904. Epub 2017 Jun 23.

引用本文的文献

1
Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌患者复发风险的预测
Asian J Urol. 2024 Oct;11(4):625-632. doi: 10.1016/j.ajur.2023.04.007. Epub 2024 Feb 23.
2
Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer.体重指数和腰围与非肌肉浸润性膀胱癌复发和进展的关系。
Cancer Med. 2023 Oct;12(20):20459-20469. doi: 10.1002/cam4.6620. Epub 2023 Oct 6.
3
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis.
吸烟对非肌肉浸润性膀胱癌复发和进展的影响:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2023 Jun;149(6):2673-2691. doi: 10.1007/s00432-022-04464-6. Epub 2022 Nov 21.
4
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.卡介苗无应答非肌层浸润性膀胱癌患者在未接受根治性膀胱切除术时的结局。
Int J Clin Oncol. 2021 Nov;26(11):2104-2112. doi: 10.1007/s10147-021-01988-8. Epub 2021 Jul 27.
5
Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway.长链非编码 RNA LINC02446 通过与 EIF3G 结合并调节 mTOR 信号通路来抑制膀胱癌细胞的增殖和转移。
Cancer Gene Ther. 2021 Dec;28(12):1376-1389. doi: 10.1038/s41417-020-00285-2. Epub 2021 Feb 2.
6
Examining the Accuracy of Self-Reported Smoking-Related Exposure among Recently Diagnosed Nonmuscle Invasive Bladder Cancer Patients.检测近期诊断为非肌肉浸润性膀胱癌患者自我报告的与吸烟相关暴露的准确性。
J Urol. 2021 May;205(5):1321-1325. doi: 10.1097/JU.0000000000001571. Epub 2020 Dec 24.